.
MergerLinks Header Logo

New Deal


Announced

Medline to acquire NAMIC from AngioDynamics for $167m.

Financials

Edit Data
Transaction Value£128m
Consideration TypeAsset Swap
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

United States

Completed

Friendly

medical devices

Medical Services

Private

Acquisition

Single Bidder

Synopsis

Edit

Medline, a manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare, agreed to acquire NAMIC from AngioDynamics, a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology, for $167m. The transaction consists of AngioDynamics’ NAMIC brand and its extensive offering of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories. Upon completion of the transaction, Medline will acquire AngioDynamics’ primary Glens Falls, New York manufacturing facility, including all related manufacturing jobs and the sales & marketing teams that support the NAMIC business. "We are excited that this strategic transaction will enable us to accelerate highly-focused investments in our key therapeutic areas including Oncology and Thrombus Management.”, Jim Clemmer AngioDynamics President.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US